Aadi Starts Small With Fyarro, But Has Tumor-Agnostic Strategy In Mind

 
• By Alaric DeArment
  
Digital illustration of Cancer cell in colour background
Aadi won FDA approval for Fyarro in PEComa, a rare form of sarcoma • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from New Products

More from Scrip